Selective regulation of IL-10 signaling and function by zymosan

被引:40
作者
Du, Zhimei
Kelly, Erin
Mecklenbrauker, Ingrid
Agle, Lucila
Herrero, Carmen
Paik, Paul
Ivashkiv, Lionel B.
机构
[1] Hosp Special Surg, Dept Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol, Ithaca, NY 14853 USA
[3] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA
[4] Hosp Special Surg, Dept Med, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.176.8.4785
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Balanced activity of pro- and anti-inflammatory cytokines during innate immune responses is required to allow effective host defense while avoiding tissue damage and autoimmunity. Induction of cytokine production after recognition of pathogen-associated molecular patterns (PAMPs). by innate immune cells has been well demonstrated, but modulation of cytokine function by PAMPs is not well understood. In this study we show that stimulation of macrophages with zymosan, which contains PAMPs derived from yeast, rapidly extinguished macrophage responses to IL-10, a suppressive cytokine that limits inflammatory tissue damage but also compromises host defense. The mechanism of inhibition involved protein kinase C beta and internalization of IL-10R, and was independent of TLR2 and phagocytosis. Inhibition of IL-10 signaling and function required direct contact with zymosan, and cells in an inflammatory environment that had not contacted zymosan remained responsive to the paracrine activity of zymosan-induced IL-10. These results reveal a mechanism that regulates IL-10 function such that antimicrobial functions of infected macrophages are not suppressed, but the activation of surrounding noninfected cells and subsequent tissue damage are limited. The fate of individual cells in an inflammatory microenvironment is thus specified by dynamic interactions among host cells, microbes, and cytokines that determine the balance between protection and pathology.
引用
收藏
页码:4785 / 4792
页数:8
相关论文
共 45 条
[1]   Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways [J].
Ahmed, ST ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5227-5237
[2]  
Ahmed ST, 2002, J LEUKOCYTE BIOL, V72, P154
[3]   Dectin-1 mediates the biological effects of β-glucans [J].
Brown, GD ;
Herre, J ;
Williams, DL ;
Willment, JA ;
Marshall, ASJ ;
Gordon, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1119-1124
[4]   Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts [J].
Deon, D ;
Ahmed, S ;
Tai, K ;
Scaletta, N ;
Herrero, C ;
Lee, IH ;
Krause, A ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5395-5403
[5]   COMPOSITION OF ZYMOSAN [J].
DICARLO, FJ ;
FIORE, JV .
SCIENCE, 1958, 127 (3301) :756-757
[6]   Cytokines, virokines and the evolution of immunity [J].
Dower, SK .
NATURE IMMUNOLOGY, 2000, 1 (05) :367-368
[7]   Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].
Fedorak, RN ;
Gangl, A ;
Elson, CO ;
Rutgeerts, P ;
Schreiber, S ;
Wild, G ;
Hanauer, SB ;
Kilian, A ;
Cohard, M ;
LeBeaut, A ;
Feagan, B .
GASTROENTEROLOGY, 2000, 119 (06) :1473-1482
[8]   Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2 [J].
Gantner, BN ;
Simmons, RM ;
Canavera, SJ ;
Akira, S ;
Underhill, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1107-1117
[9]   B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1α chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4 [J].
Guinamard, R ;
Signoret, N ;
Masamichi, I ;
Marsh, M ;
Kurosaki, T ;
Ravetch, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1461-1466
[10]   Reprogramming of IL-10 activity and signaling by IFN-γ1 [J].
Herrero, C ;
Hu, XY ;
Li, WP ;
Samuels, S ;
Sharif, MN ;
Kotenko, S ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :5034-5041